Hypokinetic dysarthria (HD) occurs in 90% of Parkinson's disease (PD) patients. It manifests
specifically in the areas of articulation, phonation, prosody, speech fluency, and faciokinesis …

The purpose of this paper is to review and evaluate measures of speech production that
could be used to document effects of Deep Brain Stimulation (DBS) on speech performance …

Objectives To elucidate the phenotypes and pathophysiology of speech and voice disorders
in Parkinson's disease (PD) with subthalamic nucleus deep brain stimulation (STN-DBS) …

Abstract LSVT® LOUD (Lee Silverman Voice Treatment) is efficacious in the treatment of
speech disorders in idiopathic Parkinson's disease (IPD), particularly hypophonia …

Cross-linguistic studies aim at determining the similarities and differences in speech
production by uncovering linguistic adaptations to specific constraints and environments. In …

PURPOSE: Intensive voice therapy (LSVT® LOUD) can effectively manage voice and
speech symptoms associated with idiopathic Parkinson disease (PD). This small-group …

Parkinson disease (PD) is a complex, progressive, neurodegenerative disorder that leads to
a wide range of deficits including fine and gross sensorimotor impairment, autonomic …

OBJECTIVE Patients with Parkinson disease (PD) who undergo subthalamic nucleus (STN)
deep brain stimulation (DBS) often develop a deterioration in speech performance, but there …

BACKGROUND: Transcranial magnetic stimulation (TMS) has been used in both
physiological studies and, more recently, the therapy of Parkinson's Disease (PD). Prior TMS …

Introduction Speech difficulties are a common debilitating feature of Parkinson's disease and
we aimed to investigate whether speech difficulties are associated with striatal dopaminergic …